BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Natus Medical Announces Third Quarter 2021 Financial Results

  Natus Medical Incorporated today announced financial results for the three and nine months ended September 30, 2021.

  November 4, 2021

   · 

  18 min read
• Business

  Neoleukin Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Update

  Neoleukin Therapeutics, Inc., today announced financial results and a corporate update for the third quarter ended September 30, 2021.

  November 4, 2021

   · 

  8 min read
• Business

  Viridian Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Updates

  Viridian Therapeutics, Inc. today announced financial results for the third quarter ended September 30, 2021, and provided corporate updates.

  November 4, 2021

   · 

  13 min read
• Business

  Assertio Reports Third Quarter 2021 Financial Results

  Assertio Holdings, Inc., a leading commercial pharmaceutical company bringing differentiated products to patients, reported financial results for the third quarter ended September 30, 2021.

  November 4, 2021

   · 

  21 min read
• Business

  Apria Announces Financial Results for Third Quarter 2021

  Apria, Inc., a leading provider of integrated home healthcare equipment and related services in the United States, announced financial results for the third quarter ended September 30, 2021.

  November 4, 2021

   · 

  12 min read
• Business

  PROCEPT BioRobotics Corp. Reports Third Quarter 2021 Financial Results and Provides 2021 Revenue Guidance

  PROCEPT® BioRobotics Corporation, a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, reported financial results for the quarter ended September 30, 2021.

  November 4, 2021

   · 

  8 min read
• Business

  Morphic Announces Corporate Highlights and Third Quarter 2021 Financial Results

  Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, reported corporate highlights and financial results for the third quarter of 2021.

  November 4, 2021

   · 

  8 min read
• Business

  Fate Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Operational Progress

  Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, reported business highlights and financial results for the third quarter ended September 30, 2021.

  November 4, 2021

   · 

  24 min read
• Biotech Beach

  ClearPoint Neuro to Present at the 2021 Stifel Virtual Healthcare Conference

  ClearPoint Neuro, Inc. announced today that its management will present at the 2021 Stifel Virtual Healthcare Conference on Tuesday, November 16, 2021 at 10:40 a.m. Eastern Time

  November 4, 2021

   · 

  2 min read
• Business

  Bellicum Reports Third Quarter 2021 Financial Results and Provides Operational Update

  Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers, reported financial results for the third quarter 2021 and provided an operational update.

  November 4, 2021

   · 

  10 min read